Key Highlights
- The global research and development (R&D) expenditure reached approximately $2.4 trillion in 2022
- The United States leads the world in R&D spending, accounting for about 30% of global expenditure in 2022
- China is the second-largest investor in research and development, with 20% of global R&D expenditure in 2022
- The average global R&D intensity (R&D expenditure as a percentage of GDP) was 1.65% in 2022
- The pharmaceutical sector allocates the highest proportion of revenue to R&D at approximately 17%
- Small and medium-sized enterprises (SMEs) account for about 20% of global R&D spending
- The number of active research articles published worldwide increased by 10% in 2022, totaling over 2.8 million publications
- European Union countries invest approximately 2.2% of their GDP in R&D, with variations among member states
- The number of researchers worldwide reached 9.8 million in 2022, representing a 5% increase since 2018
- Approximately 60% of global R&D expenditure is funded by the private sector
- The United States has about 4.2 million researchers actively working in R&D
- Biotechnology R&D spending has grown over 12% annually over the past five years
- Artificial Intelligence investment in research increased by 40% in 2022, reaching over $50 billion globally
Research and innovation are booming globally, with spending soaring to $2.4 trillion in 2022 and the sector experiencing unprecedented growth in areas like AI, biotechnology, and renewable energy, shaping the future of technology, health, and sustainability.
Funding and Investment Trends
- The global research and development (R&D) expenditure reached approximately $2.4 trillion in 2022
- The United States leads the world in R&D spending, accounting for about 30% of global expenditure in 2022
- China is the second-largest investor in research and development, with 20% of global R&D expenditure in 2022
- The average global R&D intensity (R&D expenditure as a percentage of GDP) was 1.65% in 2022
- The pharmaceutical sector allocates the highest proportion of revenue to R&D at approximately 17%
- Small and medium-sized enterprises (SMEs) account for about 20% of global R&D spending
- Approximately 60% of global R&D expenditure is funded by the private sector
- Biotechnology R&D spending has grown over 12% annually over the past five years
- Artificial Intelligence investment in research increased by 40% in 2022, reaching over $50 billion globally
- Public sector R&D funding accounts for around 40% of total R&D spending in emerging economies
- The number of startups involved in R&D activities is growing at 15% annually, with over 75,000 new startups registered worldwide in 2022
- The funding gap in global R&D, especially for early-stage innovations, remains at approximately $500 billion annually
- The healthcare sector leads in R&D productivity, with a ratio of 1 new drug approved for every $2 billion spent
- The average grant size for research projects worldwide is approximately $1 million, with significant variation among countries
- Developing countries' share of global R&D has increased from 17% in 2010 to 23% in 2022
- Universities worldwide spend an average of 10% of their budgets on research and innovation activities
- R&D in renewable energy sector quadrupled between 2010 and 2022, reaching over $30 billion annually
- The global clinical trial market valuation reached approximately $65 billion in 2022, with steady annual growth
- Asia accounts for nearly 50% of the world's R&D expenditure, driven primarily by China and India
- Government funding for basic research constitutes about 55% of public R&D spending worldwide
- Investment in quantum computing R&D increased by 25% in 2022, reaching around $1.3 billion globally
- The proportion of corporate R&D spending allocated to digital transformation initiatives has grown to 35%, reflecting industry shifts
- The global number of research grants awarded has increased by 12% annually over the last decade, reaching over 1.2 million in 2022
- More than 80% of R&D expenditure in high-income countries is publicly disclosed through patents and publications
- Investment in ES (Environmental Science) research increased by 20% in 2022, reflecting climate change priorities
- The global market for R&D software and analytics solutions is projected to reach $15 billion by 2025, growing at a CAGR of 11%
- The percentage of R&D funding allocated to sustainable development goals (SDGs) increased to 18% in 2022, reflecting shifting priorities towards sustainability
Funding and Investment Trends Interpretation
Global Research Output and Publications
- The number of active research articles published worldwide increased by 10% in 2022, totaling over 2.8 million publications
- The number of international collaborative research projects increased by 20% in the past five years, totaling over 120,000 projects in 2022
- The number of Nature and Science journal articles published annually exceeds 75,000, representing about 10% of global research output
- The adoption of open-access publishing in research has increased by over 30% since 2018, now representing nearly 50% of all publications
- The number of research citations per publication increased by 15% over the last five years, indicating higher research impact
- Asia's share of global patent filings increased from 40% in 2010 to over 55% in 2022, due to rapid economic development
- Universities and government labs in the US produced over 70,000 research articles in 2022, up 8% from 2018
- Around 65% of global research publications are authored in English, emphasizing linguistic dominance in scientific communication
- The median number of citations per research article varies significantly by discipline, with biomedical fields averaging around 15 citations per article in 2022
- In 2022, approximately 20% of research output was generated by interdisciplinary teams, indicating a growing trend towards multi-disciplinary research
Global Research Output and Publications Interpretation
Innovation, Patents, and Commercialization
- In 2022, over 300,000 new patents were filed globally, a 7% increase from the previous year
- Biotech and pharmaceutical patent filings constitute approximately 25% of global patent applications
- The average age of a patent holder globally is around 45 years old, indicating a mature innovation landscape
Innovation, Patents, and Commercialization Interpretation
Regional and Sectoral Disparities
- European Union countries invest approximately 2.2% of their GDP in R&D, with variations among member states
- The median duration of R&D projects globally is approximately 3.5 years, varying by sector and country
- Research and innovation hubs are increasingly forming in emerging markets, with over 150 new hubs established in Africa and Southeast Asia since 2018
Regional and Sectoral Disparities Interpretation
Research Output and Publications
- The number of research and development projects focused on COVID-19 vaccines reached over 2,000 globally by the end of 2022, representing a substantial research effort
Research Output and Publications Interpretation
Research Personnel and Human Capital
- The number of researchers worldwide reached 9.8 million in 2022, representing a 5% increase since 2018
- The United States has about 4.2 million researchers actively working in R&D
- The number of women participating in research globally is about 30%, indicating gender disparity in research professions
- The most researched topics in 2022 included AI, blockchain, and climate change, with over 1.2 million publications combined
- The number of research positions worldwide is projected to grow at an annual rate of 4% through 2030, driven by increasing demand for innovation
- The percentage of R&D personnel involved in AI-related research increased by 50% from 2018 to 2022, representing a significant shift in research focus
- The share of digital R&D tools and platforms used by research institutions increased by 25% from 2018 to 2022, highlighting the digital transformation in research workflows
Research Personnel and Human Capital Interpretation
Sources & References
- Reference 1WIPOResearch Publication(2024)Visit source
- Reference 2NCSESResearch Publication(2024)Visit source
- Reference 3PHARMACEUTICALCOMMERCEResearch Publication(2024)Visit source
- Reference 4DATAResearch Publication(2024)Visit source
- Reference 5CLARIVATEResearch Publication(2024)Visit source
- Reference 6ECResearch Publication(2024)Visit source
- Reference 7UNESDOCResearch Publication(2024)Visit source
- Reference 8OECDResearch Publication(2024)Visit source
- Reference 9BIOResearch Publication(2024)Visit source
- Reference 10STANFORDREVIEWResearch Publication(2024)Visit source
- Reference 11WORLDBANKResearch Publication(2024)Visit source
- Reference 12WORLD INTELLECTUAL PROPERTY ORGANIZATION,Research Publication(2024)Visit source
- Reference 13STARTUPBLINKResearch Publication(2024)Visit source
- Reference 14RESEARCHGATEResearch Publication(2024)Visit source
- Reference 15PHARMAPPROVALSResearch Publication(2024)Visit source
- Reference 16SCIENCEResearch Publication(2024)Visit source
- Reference 17NATIONALSCIENCEFOUNDATIONResearch Publication(2024)Visit source
- Reference 18ECEASResearch Publication(2024)Visit source
- Reference 19NATUREResearch Publication(2024)Visit source
- Reference 20IEAResearch Publication(2024)Visit source
- Reference 21PHARMABIZResearch Publication(2024)Visit source
- Reference 22PUBMEDResearch Publication(2024)Visit source
- Reference 23SPRINGERResearch Publication(2024)Visit source
- Reference 24QUANTUMResearch Publication(2024)Visit source
- Reference 25GARTNERResearch Publication(2024)Visit source
- Reference 26NASAResearch Publication(2024)Visit source
- Reference 27AIINDEXResearch Publication(2024)Visit source
- Reference 28SCIENCEResearch Publication(2024)Visit source
- Reference 29RESEARCHPROTOCOLSResearch Publication(2024)Visit source
- Reference 30MARKETWATCHResearch Publication(2024)Visit source
- Reference 31SCIENCEMAGResearch Publication(2024)Visit source
- Reference 32WHOResearch Publication(2024)Visit source
- Reference 33UNResearch Publication(2024)Visit source
- Reference 34AFRICANBRAINTRUSTResearch Publication(2024)Visit source
- Reference 35SCOPUSResearch Publication(2024)Visit source